Brief: Niagen Bioscience Increases Full Year 2025 Net Sales Outlook To 25% To 30% Year-Over-Year Growth
06/10/2025 13:43
Oct 6 (Reuters) - Niagen Bioscience Inc NAGE.O: REASES FULL YEAR 2025 NET SALES OUTLOOK TO 25% TO 30% YEAR-OVER-YEAR GROWTH FY2025 REVENUE VIEW $125.9 MILLION -- LSEG IBES DATA Source text: ID:nBw2yD4P7a Further company coverage: NAGE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce